Skip to main content
. 2015 Feb 20;128(4):427–432. doi: 10.4103/0366-6999.151057

Figure 1.

Figure 1

Kupperman menopausal index score before and after gonadotropin releasing hormone agonist (GnRH-a) therapy. *P < 0.05, **P < 0.01 versus the same group at 0 week of GnRH-a therapy; P < 0.05 versus Tibolone group 4 week after GnRH-a therapy; P < 0.01 versus control group 8 week or 12 week after GnRH-a therapy.